FDA label
What is Oxervate used for?
Oxervate contains cenegermin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “OXERVATE® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Oxervate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Oxervate, solution/ drops
Indications and Usage, quoted from the label by Dompé farmaceutici S.p.A. (BLA761094). Cross-references to other label sections are left out.
OXERVATE® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.
Source: DailyMed label, set id 89e4bfec-d710-40ed-8885-5d13ba46b1cd, version 16, effective October 5, 2026. NDC 71981-020, one of 1 listing for this product.
Questions
What is Oxervate used for?
The FDA label says: “OXERVATE® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.”
What drug class is Oxervate?
FDA lists cenegermin in the Recombinant Human Nerve Growth Factor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.